Spironolactone Tablet, Film Coated
Product Images NDC 55154-5517

This is a description of a medication called Spironolactone in a 25mg dose. The medication is in tablet form, with 10 tablets in each container. There are instructions to refer to the product insert for more dosage information, precautions, and warnings. The recommended storage condition is at 20-25°C, with protection from light. The package contains a warning that it is intended for institutional use only and is not child-resistant. The medication is manufactured by Mylan Pharmaceuticals Inc. in West Virginia, U.S.A, and distributed by Mylan Institutional Inc. in Illinois, U.S.A, and Cardinal Health in Ohio, U.S.A.*

This appears to be a table of medical data, possibly related to heart failure. The categories include subgroup, age range, sex, race, left ventricular ejection fraction (LVEF), heart failure classification based on NYHA criteria, diabetes, serum creatinine levels, estimated creatinine clearance, potassium levels, medication use (including digoxin, beta blockers, and ACE inhibitors), and the results of certain tests (such as the proportion of patients with ischemic vs non-ischemic heart disease). It appears that there are some missing values or not-applicable categories. The last row suggests that the table may be related to a study comparing the effectiveness of spironolactone vs placebo for treating heart failure.*